Onychomycosis (Tinea Unguium) Drug  Market Report

Global and Region Onychomycosis (Tinea Unguium) Drug  Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：139
  • REPORT CODE：GMM952909
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Onychomycosis (Tinea Unguium) Drug  market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Onychomycosis (Tinea Unguium) Drug market, defines the market attractiveness level of Onychomycosis (Tinea Unguium) Drug  market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Onychomycosis (Tinea Unguium) Drug  industry, describes the types of Onychomycosis (Tinea Unguium) Drug  market, the applications of major players and the market size, and deeply analyzes the current situation of the global Onychomycosis (Tinea Unguium) Drug  market and the development prospects and opportunities of Onychomycosis (Tinea Unguium) Drug  industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Onychomycosis (Tinea Unguium) Drug  market in Chapter 13.

    By Player:

    • Pfizer

    • Kaken Pharmaceutical

    • Xiuzheng Pharmaceutical

    • Novartis

    • Valeant Pharma

    • Qilu Pharmaceutical

    • GSK

    • Johnson and Johnson

    • Galderma

    • Letai

    By Type:

    • Oral Medication

    • External Medicine

    By End-User:

    • Age under 18

    • Age 18-50

    • Age above 50

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Onychomycosis (Tinea Unguium) Drug  Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Onychomycosis (Tinea Unguium) Drug  Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Onychomycosis (Tinea Unguium) Drug  Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Onychomycosis (Tinea Unguium) Drug  Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Onychomycosis (Tinea Unguium) Drug  Market Analysis and Outlook to 2022

    • 7.1 Global Onychomycosis (Tinea Unguium) Drug  Consumption (2017-2022)

    • 7.2 United States Onychomycosis (Tinea Unguium) Drug  Consumption (2017-2022)

    • 7.3 Europe Onychomycosis (Tinea Unguium) Drug  Consumption (2017-2022)

    • 7.4 China Onychomycosis (Tinea Unguium) Drug  Consumption (2017-2022)

    • 7.5 Japan Onychomycosis (Tinea Unguium) Drug  Consumption (2017-2022)

    • 7.6 India Onychomycosis (Tinea Unguium) Drug  Consumption (2017-2022)

    • 7.7 South Korea Onychomycosis (Tinea Unguium) Drug  Consumption (2017-2022)

    8 Region and Country-wise Onychomycosis (Tinea Unguium) Drug  Market Analysis and Outlook to 2028

    • 8.1 Global Onychomycosis (Tinea Unguium) Drug  Consumption Forecast (2022-2028)

    • 8.2 United States Onychomycosis (Tinea Unguium) Drug  Consumption Forecast (2022-2028)

    • 8.3 Europe Onychomycosis (Tinea Unguium) Drug  Consumption Forecast (2022-2028)

    • 8.4 China Onychomycosis (Tinea Unguium) Drug  Consumption Forecast (2022-2028)

    • 8.5 Japan Onychomycosis (Tinea Unguium) Drug  Consumption Forecast (2022-2028)

    • 8.6 India Onychomycosis (Tinea Unguium) Drug  Consumption Forecast (2022-2028)

    • 8.7 South Korea Onychomycosis (Tinea Unguium) Drug  Consumption Forecast (2022-2028)

    9 Global Onychomycosis (Tinea Unguium) Drug  Market Outlook by Types and Applications to 2022

    • 9.1 Global Onychomycosis (Tinea Unguium) Drug  Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Medication Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global External Medicine Consumption and Growth Rate (2017-2022)

    • 9.2 Global Onychomycosis (Tinea Unguium) Drug  Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Age under 18 Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Age 18-50 Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Age above 50 Consumption and Growth Rate (2017-2022)

    10 Global Onychomycosis (Tinea Unguium) Drug  Market Outlook by Types and Applications to 2028

    • 10.1 Global Onychomycosis (Tinea Unguium) Drug  Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Oral Medication Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global External Medicine Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Onychomycosis (Tinea Unguium) Drug  Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Age under 18 Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Age 18-50 Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Age above 50 Consumption Forecast and Growth Rate (2022-2028)

    11 Global Onychomycosis (Tinea Unguium) Drug  Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Onychomycosis (Tinea Unguium) Drug  Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Onychomycosis (Tinea Unguium) Drug  Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Onychomycosis (Tinea Unguium) Drug  Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Onychomycosis (Tinea Unguium) Drug  Market Competitive Analysis

    • 14.1 Pfizer

      • 14.1.1 Pfizer Company Details

      • 14.1.2 Pfizer Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Pfizer Onychomycosis (Tinea Unguium) Drug  Product and Service

    • 14.2 Kaken Pharmaceutical

      • 14.2.1 Kaken Pharmaceutical Company Details

      • 14.2.2 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Product and Service

    • 14.3 Xiuzheng Pharmaceutical

      • 14.3.1 Xiuzheng Pharmaceutical Company Details

      • 14.3.2 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Product and Service

    • 14.4 Novartis

      • 14.4.1 Novartis Company Details

      • 14.4.2 Novartis Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Novartis Onychomycosis (Tinea Unguium) Drug  Product and Service

    • 14.5 Valeant Pharma

      • 14.5.1 Valeant Pharma Company Details

      • 14.5.2 Valeant Pharma Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug  Product and Service

    • 14.6 Qilu Pharmaceutical

      • 14.6.1 Qilu Pharmaceutical Company Details

      • 14.6.2 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Product and Service

    • 14.7 GSK

      • 14.7.1 GSK Company Details

      • 14.7.2 GSK Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 GSK Onychomycosis (Tinea Unguium) Drug  Product and Service

    • 14.8 Johnson and Johnson

      • 14.8.1 Johnson and Johnson Company Details

      • 14.8.2 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug  Product and Service

    • 14.9 Galderma

      • 14.9.1 Galderma Company Details

      • 14.9.2 Galderma Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Galderma Onychomycosis (Tinea Unguium) Drug  Product and Service

    • 14.10 Letai

      • 14.10.1 Letai Company Details

      • 14.10.2 Letai Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Letai Onychomycosis (Tinea Unguium) Drug  Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Onychomycosis (Tinea Unguium) Drug 

    • Figure Onychomycosis (Tinea Unguium) Drug  Picture

    • Table Global Onychomycosis (Tinea Unguium) Drug  Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Onychomycosis (Tinea Unguium) Drug  Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Onychomycosis (Tinea Unguium) Drug  Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Onychomycosis (Tinea Unguium) Drug  Consumption by Country (2017-2022)

    • Figure United States Onychomycosis (Tinea Unguium) Drug  Consumption and Growth Rate (2017-2022)

    • Table Europe Onychomycosis (Tinea Unguium) Drug  Consumption and Growth Rate (2017-2022)

    • Figure China Onychomycosis (Tinea Unguium) Drug  Consumption and Growth Rate (2017-2022)

    • Figure Japan Onychomycosis (Tinea Unguium) Drug  Consumption and Growth Rate (2017-2022)

    • Figure India Onychomycosis (Tinea Unguium) Drug  Consumption and Growth Rate (2017-2022)

    • Figure South Korea Onychomycosis (Tinea Unguium) Drug  Consumption and Growth Rate (2017-2022)

    • Figure Global Onychomycosis (Tinea Unguium) Drug  Consumption Forecast by Country (2022-2028)

    • Figure United States Onychomycosis (Tinea Unguium) Drug  Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Onychomycosis (Tinea Unguium) Drug  Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Onychomycosis (Tinea Unguium) Drug  Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Onychomycosis (Tinea Unguium) Drug  Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Onychomycosis (Tinea Unguium) Drug  Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Onychomycosis (Tinea Unguium) Drug  Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Medication Consumption and Growth Rate (2017-2022)

    • Figure Global External Medicine Consumption and Growth Rate (2017-2022)

    • Figure Global Age under 18 Consumption and Growth Rate (2017-2022)

    • Figure Global Age 18-50 Consumption and Growth Rate (2017-2022)

    • Figure Global Age above 50 Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Medication Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global External Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Age under 18 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Age 18-50 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Age above 50 Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Onychomycosis (Tinea Unguium) Drug  Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Onychomycosis (Tinea Unguium) Drug  Export by Region (Top 5 Countries) (2017-2028)

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Onychomycosis (Tinea Unguium) Drug  Product and Service

    • Table Kaken Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Product and Service

    • Table Xiuzheng Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

    • Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Onychomycosis (Tinea Unguium) Drug  Product and Service

    • Table Valeant Pharma (Foundation Year, Company Profile and etc.)

    • Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug  Product and Service

    • Table Qilu Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Onychomycosis (Tinea Unguium) Drug  Product and Service

    • Table Johnson and Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson and Johnson Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson and Johnson Onychomycosis (Tinea Unguium) Drug  Product and Service

    • Table Galderma (Foundation Year, Company Profile and etc.)

    • Table Galderma Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

    • Table Galderma Onychomycosis (Tinea Unguium) Drug  Product and Service

    • Table Letai (Foundation Year, Company Profile and etc.)

    • Table Letai Onychomycosis (Tinea Unguium) Drug  Sales, Price, Value and Gross Profit (2017-2022)

    • Table Letai Onychomycosis (Tinea Unguium) Drug  Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US